| pubmed-article:3663351 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:3663351 | lifeskim:mentions | umls-concept:C0035412 | lld:lifeskim |
| pubmed-article:3663351 | lifeskim:mentions | umls-concept:C0020629 | lld:lifeskim |
| pubmed-article:3663351 | lifeskim:mentions | umls-concept:C1317750 | lld:lifeskim |
| pubmed-article:3663351 | lifeskim:mentions | umls-concept:C1521725 | lld:lifeskim |
| pubmed-article:3663351 | lifeskim:mentions | umls-concept:C2827582 | lld:lifeskim |
| pubmed-article:3663351 | pubmed:issue | 11 | lld:pubmed |
| pubmed-article:3663351 | pubmed:dateCreated | 1987-11-24 | lld:pubmed |
| pubmed-article:3663351 | pubmed:abstractText | Eighty-nine children with localized rhabdomyosarcoma of orofacial and laryngopharyngeal sites were treated in accordance with the first and second Intergroup Rhabdomyosarcoma Study (IRS) protocols (IRS-I and IRS-II) between 1972 and 1984. Treatment included surgery (or biopsy) and chemotherapy for all patients and radiotherapy in the majority. The actuarial estimate of the three-year survival rate for all patients was 83% and did not differ significantly by primary site, histologic findings, or presence of adenopathy. A trend for a worse survival rate was seen in clinical group III patients and in those less than 5 years of age at diagnosis. Factors associated with an increased risk of local/regional relapse included omission of radiotherapy and a radiation dose of less than 40 Gy (4000 rad). We conclude that treatment of these patients as recommended in the IRS-I and IRS-II protocols results in very good local and regional tumor control and survival rates. Salvage therapy for local/regional recurrence may yield long-term remission and possibly cure. | lld:pubmed |
| pubmed-article:3663351 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3663351 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3663351 | pubmed:grant | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3663351 | pubmed:language | eng | lld:pubmed |
| pubmed-article:3663351 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:3663351 | pubmed:citationSubset | AIM | lld:pubmed |
| pubmed-article:3663351 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:3663351 | pubmed:month | Nov | lld:pubmed |
| pubmed-article:3663351 | pubmed:issn | 0886-4470 | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:MaurerH MHM | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:WharamM DMD | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:TefftMM | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:SAVEL | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:SouleE HEH | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:RuymannF BFB | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:LawrenceWW | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:HeynR MRM | lld:pubmed |
| pubmed-article:3663351 | pubmed:author | pubmed-author:BeltangadyM... | lld:pubmed |
| pubmed-article:3663351 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:3663351 | pubmed:volume | 113 | lld:pubmed |
| pubmed-article:3663351 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:3663351 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:3663351 | pubmed:pagination | 1225-7 | lld:pubmed |
| pubmed-article:3663351 | pubmed:dateRevised | 2007-11-14 | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:meshHeading | pubmed-meshheading:3663351-... | lld:pubmed |
| pubmed-article:3663351 | pubmed:year | 1987 | lld:pubmed |
| pubmed-article:3663351 | pubmed:articleTitle | Pediatric orofacial and laryngopharyngeal rhabdomyosarcoma. An Intergroup Rhabdomyosarcoma Study report. | lld:pubmed |
| pubmed-article:3663351 | pubmed:affiliation | Division of Radiation Oncology, Johns Hopkins Oncology Center, Baltimore, MD 21205. | lld:pubmed |
| pubmed-article:3663351 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:3663351 | pubmed:publicationType | Research Support, U.S. Gov't, P.H.S. | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:3663351 | lld:pubmed |
